Table 3.
Distribution of comorbidities among respondents in second observations
| Variable | Post-COVID-19 Conditions patients (n = 389) | Recovery (n = 40) | Death (n = 9) | |||
|---|---|---|---|---|---|---|
| Frequency | Percentage | Frequency | Percentage | Frequency | Percentage | |
| Diabetes | 223 | (57.3%) | 22 | (55.0%) | 04 | (44.4%) |
| Hypertension | 218 | (56.0%) | 21 | (52.5%) | 07 | (77.8%) |
| IHD | 71 | (18.3%) | 09 | (22.5%) | 02 | (22.2%) |
| COPD | 84 | (21.6%) | 11 | (27.5%) | 01 | (11.1%) |
| Chronic Kidney Disease | 54 | (13.9%) | 07 | (17.5%) | 01 | (11.1%) |
| Hypothyroidism | 41 | (10.5%) | 06 | (15.0%) | 01 | (11.1%) |
| UTI | 03 | (0.8%) | 00 | (0%) | 01 | (11.1%) |
| Osteoporosis | 91 | (23.4%) | 09 | (22.5%) | 02 | (22.2%) |
| High Cholesterol | 06 | (1.5%) | 02 | (5.0%) | 00 | (0%) |
IHD: Ischemic Heart Disease; COPD: Chronic Obstructive Pulmonary Disease; UTI: Urinary Tract Infection